Danish National Randomized Study on Early Aortic Valve Replacement in Patients With Asymptomatic Severe Aortic Stenosis

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-85
SponsorOdense University Hospital

About this trial

The purpose of this study is to examine the impact of early surgery in patients with asymptomatic severe aortic valve stenosis with signs of subclinical LV dysfunction despite preserved LVEF, with a watchfull waiting approach.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

1. Severe AS defined as

aortic valve area (AVA) ≤1 cm2, AND

Transvalvular maximum velocity (Vmax) ≥3.5 m/s AND

AS severity evaluated severe by a heart valve team conference. In cases where severity is not unambiguous an integrative approach will be utilized combining echocardiographic markers of valve severity and LV function, and if necessary aortic valve calcification estimated by non-contrast CT.

Disqualifiers

LVEF<50%

Very severe AS defined as Vmax>5 m/s.

Concomitant severe valvular disease other than AS

Previous valvular surgery

Trial design

Design model

Parallel

Treatments tested in this trial

  • Aortic valve replacement

    Procedure/Surgery

    Open heart surgery or transcatheter surgery

Treatment groups

1,700 Participants
are divided into 2 treatment groups
Group A: Early interventionActive comparator 1 intervention
Group B: Watchfull waitingNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

all-cause mortality

All-cause mortality assessed by Danish patient records

Time frame
After 379 events (approx 5 years)

Secondary outcomes

1

Combined endpoint

All-cause mortality + hospitalization due to heart failure and stroke

Time frame
After 379 events (approx 5 years)
2

all-cause mortality in patients with low-gradient AS

All-cause mortality in patients with meangradient \<40 mmHg

Time frame
After 379 events (approx 5 years)
3

Combined endpoint in low-gradient AS

All-cause mortality + hospitalization to heart failure and stroke when MG\<40 mmHg

Time frame
After 379 events (approx 5 years)

Other outcomes

1

Pericardiocentesis

Need of pericariocentesis

Time frame
5 years
2

sternal infection

hospitalization due to sternal infection

Time frame
5 years
3

Persistent renal failure

complete loss of renal function exceeding 4 weeks.

Time frame
5 years
4

endocarditis

hospitalization due to endocarditis

Time frame
5-years

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Odense University Hospital

Lead sponsor

Rigshospitalet, Denmark

Collaborator

Aarhus University Hospital

Collaborator

Aalborg University Hospital

Collaborator

Zealand University Hospital

Collaborator